Health Products

Rasilez

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
T1456A
Recalling Firm
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd.
Dorval
H9S 1A9
Quebec
CANADA
Marketing Authorization Holder
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd.
Dorval
H9S 1A9
Quebec
CANADA
A. RasilezTabletDIN 02302071300 mg

Introduction

Recalled Products
  1. Rasilez

Reason

Small number of cartons (estimated 330 cartons) with Spanish language and incorrect UPC numbers were in the shipment of Canadian product. However, the product, leaflet and blister card inside are the correct materials for the Canadian market.

Depth of distribution

Wholesalers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime